FDA Adverse Event Malfunction Summary report: N

POWERFLEX PRO PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY CATHETER

MDR report key: 2981209 · Received February 27, 2013

Report

Report Number
9616099-2013-00097
Event Type
Malfunction
Date Received
February 27, 2013
Date of Event
February 7, 2013
Report Date
February 7, 2013
Manufacturer
CORDIS DE MEXICO
Product Code
LIT
PMA / PMN Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

AS REPORTED BY THE CUSTOMER A POWERFLEX PRO 3 MM 22CM 135 BALLOON WOULD NOT DEFLATE. SEVERAL ATTEMPTS HAVE BEEN MADE TO COLLECT MORE INFORMATION ABOUT THE PATIENT, THE VESSEL CHARACTERISTICS AND DETAILS OF THE EVENT WITHOUT SUCCESS. A REVIEW OF THE MANUFACTURING DOCUMENTATION ASSOCIATED WITH THIS LOT PRESENTED NO ISSUES DURING THE MANUFACTURING PROCESS THAT CAN BE RELATED TO THE REPORTED COMPLAINT. WITHOUT THE RETURN OF THE DEVICE FOR ANALYSIS, THE REPORTED CUSTOMER COMPLAINT OF "DEFLATION DIFFICULTY-UNABLE TO" COULD NOT BE CONFIRMED. BASED ON THE VERY LIMITED INFORMATION AVAILABLE FOR REVIEW, IT IS NOT POSSIBLE TO DETERMINE WHAT FACTORS MAY HAVE CONTRIBUTED TO THE REPORTED ISSUE. NEITHER THE DHR NOR THE INFORMATION AVAILABLE FOR REVIEW INDICATE THAT THERE IS A DESIGN OR MANUFACTURING RELATED ISSUE, THEREFORE NO CORRECTIVE ACTION IS REQUIRED.

Additional Manufacturer Narrative · 1

THIS DEVICE IS NOT AVAILABLE FOR ANALYSIS. A REVIEW OF THE MANUFACTURING DOCUMENTATION ASSOCIATED WITH THIS LOT PRESENTED NO ISSUES DURING THE MANUFACTURING PROCESS THAT CAN BE RELATED TO THE REPORTED COMPLAINT. ADDITIONAL INFORMATION IS PENDING AND WILL BE SUBMITTED WITHIN 30 DAYS UPON RECEIPT.

Description of Event or Problem · 1

A PHYSICIAN REPORTED THAT A 3MM 22CM 135 POWERFLEX PRO BALLOON WOULD NOT DEFLATE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
83349 POWERFLEX PRO PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY CATHETER PTA CATHETERS LIT CORDIS DE MEXICO NA 15673158

Patients

Seq Age Sex Outcome Treatment
1